BioSpace News Archive

FDA

FDA Approves Bayer HealthCare’s Kogenate® FS Antihemophilic Factor VIII (Recombinant) For Routine Prophylaxis In Adults With Hemophilia A

May 12, 2014
·
7 min read
Deals

Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals, Inc. (Headquarters) Announce Early Termination Of HSR Act Waiting Period

May 12, 2014
·
1 min read
FDA

Halt Medical, Inc. Announces FDA Clearance Of The Acessa Guidance Hand Piece

May 12, 2014
·
2 min read
Business

BioTime Announces First Quarter 2014 Results and Recent Developments

May 12, 2014
·
1 min read
BioForest

Chase Pharmaceuticals Raises $21 Million In Series B Financing

May 12, 2014
·
6 min read
Deals

Allergan Inc. Rejects Valeant Pharmaceuticals International’s Takeover Offer

May 12, 2014
·
7 min read
Drug Development

Taiho Oncology’s TAS-102 Meets Primary Endpoint Of Improving Overall Survival In Global Phase 3 RECOURSE Trial In Refractory Metastatic Colorectal Cancer

May 12, 2014
·
5 min read
FDA

Merck & Co., Inc. Release: FDA Approves ZONTIVITY (Vorapaxar), First-In-Class PAR-1 Antagonist, For The Reduction Of Thrombotic Cardiovascular Events In Patients With A History Of Heart Attack Or With Peripheral Arterial Disease

May 12, 2014
·
11 min read
Job Trends

Pfizer Inc.'s History In U.K. Offers Hope For AstraZeneca PLC Jobs

May 12, 2014
·
1 min read
Deals

Pfizer Inc. Presses AstraZeneca PLC Case As CEO Faces UK Grilling

May 12, 2014
·
1 min read